Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "IFF"

1593 News Found

IFF to acquire contract manufacturer of dietary supplements Health Wright Products
News | February 22, 2022

IFF to acquire contract manufacturer of dietary supplements Health Wright Products

The sale is expected to close in the first quarter of 2022


Skye Air Mobility to deploy drones to enhance Redcliffe Labs services
Clinical Trials | February 10, 2022

Skye Air Mobility to deploy drones to enhance Redcliffe Labs services

Urban, semi-urban and remote corners of the country will be catered using drone delivery technology


Redcliffe Labs appoints Abhay Singavi as Chief Business Officer
People | February 07, 2022

Redcliffe Labs appoints Abhay Singavi as Chief Business Officer

Takes charge to lead business innovation, strategy, alliance & partnerships


Green chemistry approaches to synthesis could make a big difference to pharma product outputs
News | January 20, 2022

Green chemistry approaches to synthesis could make a big difference to pharma product outputs

Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies


Redcliffe Labs chalks out aggressive expansion plans
Clinical Trials | December 08, 2021

Redcliffe Labs chalks out aggressive expansion plans

It plans to add over 1000 employees over the next six months


Antengene and MindRank AI to advance the development of difficult-to-drug molecular targets
Drug Approval | August 09, 2021

Antengene and MindRank AI to advance the development of difficult-to-drug molecular targets

Both companies aim to improve the efficiency and success rate of the current drug discovery process.


Innovent Biologics’ OLN324 shows breakthrough results in vision disease study
Biopharma | April 05, 2026

Innovent Biologics’ OLN324 shows breakthrough results in vision disease study

The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred


Concord Biotech acquires Celliimune to accelerate DNA-engineered cancer therapies
Biotech | April 04, 2026

Concord Biotech acquires Celliimune to accelerate DNA-engineered cancer therapies

Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy


Sun Pharma flags mixed Fibromun trial results, advances new Phase III study in soft tissue sarcoma
Biotech | April 04, 2026

Sun Pharma flags mixed Fibromun trial results, advances new Phase III study in soft tissue sarcoma

The company has highlighted setbacks in Phase II studies while outlining fresh regulatory and late-stage development plans for Fibromun and Nidlegy


Abbott launches nationwide Vitamin C awareness campaign
Healthcare | April 04, 2026

Abbott launches nationwide Vitamin C awareness campaign

The company spotlights micronutrient’s role in immunity, skin and bone health through digital and radio outreach on National Vitamin C Day